In this chapter:
(1) “Hemophilia” means a human physical condition characterized by bleeding resulting from a genetically or hereditarily determined deficiency of a blood coagulation factor resulting in an abnormal or deficient plasma procoagulant.
(2) “Other benefit” means a benefit, other than a benefit under this chapter, to which a person is entitled for payment of the costs of blood factor replacement products and other substances provided under this chapter, including benefits available from:
(A) an insurance policy, group health plan, or prepaid medical or dental care plan;
(B) Title XVIII or Title XIX of the Social Security Act (42 U.S.C. § 1395 et seq. or 42 U.S.C. § 1396 et seq.);
(C) the United States Department of Veterans Affairs;
(D) the TRICARE program of the United States Department of Defense;
(E) workers’ compensation or any compulsory employers’ insurance program;
(F) a public program created by federal law, state law, or the ordinances or rules of a municipality or political subdivision of the state, excluding benefits created by the establishment of a municipal or county hospital, a joint municipal-county hospital, a county hospital authority, a hospital district, or the facilities of a publicly supported medical school; or
(G) a cause of action for medical or dental expenses to a person applying for or receiving services from the department, or a settlement or judgment based on the cause of action, if the expenses are related to the need for services provided under this chapter.